OBJECTIVE: The coloured population has the second-highest prevalence of diabetes in South Africa. However, the data were based on a study conducted almost 20 years ago in a peri-urban coloured population of the Western Cape. We aimed to determine the prevalence of diabetes mellitus and metabolic syndrome in an urban coloured population in South Africa. DESIGN: In a cross-sectional survey, 642 participants aged ≥31 years were drawn from an urban community of Bellville South, Cape Town, from mid-January 2008 to March 2009. Type 2 diabetes was assessed according to the WHO criteria, and metabolic syndrome was based on the International Diabetes Federation (IDF), ATP III and 2009 Joint Interim Statement (JIS) definition. RESULTS: The crude prevalence of 28.2% (age-adjusted 26.3%, 95% confidence interval (CI) 22.0 - 30.3) for type 2 diabetes was: 4.4% (age-adjusted 3.2%, 95% CI 1.6 - 4.9) for impaired fasting glycaemia, and 15.3% (age-adjusted 15.0%, 95% CI 11.4 - 18.6) for impaired glucose tolerance. Undiagnosed type 2 diabetes was present in 18.1% (age-adjusted 16.8%, 95% CI 13.3 - 20.4). The crude prevalence of metabolic syndrome was higher with the JIS definition (62.0%) than the IDF (60.6%), and the National Cholesterol Education Program (NCEP) ATP III (55.4%). There was good overall agreement between the MetS criteria, k=0.89 (95% CI 0.85 - 0.92). CONCLUSION: The prevalence of diabetes has increased hugely in the coloured community, and the high prevalence of undiagnosed diabetes portends that cardiovascular diseases might grow to epidemic proportions in the near future in South Africa.
OBJECTIVE: The coloured population has the second-highest prevalence of diabetes in South Africa. However, the data were based on a study conducted almost 20 years ago in a peri-urban coloured population of the Western Cape. We aimed to determine the prevalence of diabetes mellitus and metabolic syndrome in an urban coloured population in South Africa. DESIGN: In a cross-sectional survey, 642 participants aged ≥31 years were drawn from an urban community of Bellville South, Cape Town, from mid-January 2008 to March 2009. Type 2 diabetes was assessed according to the WHO criteria, and metabolic syndrome was based on the International Diabetes Federation (IDF), ATP III and 2009 Joint Interim Statement (JIS) definition. RESULTS: The crude prevalence of 28.2% (age-adjusted 26.3%, 95% confidence interval (CI) 22.0 - 30.3) for type 2 diabetes was: 4.4% (age-adjusted 3.2%, 95% CI 1.6 - 4.9) for impaired fasting glycaemia, and 15.3% (age-adjusted 15.0%, 95% CI 11.4 - 18.6) for impaired glucose tolerance. Undiagnosed type 2 diabetes was present in 18.1% (age-adjusted 16.8%, 95% CI 13.3 - 20.4). The crude prevalence of metabolic syndrome was higher with the JIS definition (62.0%) than the IDF (60.6%), and the National Cholesterol Education Program (NCEP) ATP III (55.4%). There was good overall agreement between the MetS criteria, k=0.89 (95% CI 0.85 - 0.92). CONCLUSION: The prevalence of diabetes has increased hugely in the coloured community, and the high prevalence of undiagnosed diabetes portends that cardiovascular diseases might grow to epidemic proportions in the near future in South Africa.
Authors: Blanca I Restrepo; Léanie Kleynhans; Alejandra B Salinas; Bassent Abdelbary; Happy Tshivhula; Genesis P Aguillón-Durán; Carine Kunsevi-Kilola; Gloria Salinas; Kim Stanley; Stephanus T Malherbe; Elizna Maasdorp; Moncerrato Garcia-Viveros; Ilze Louw; Esperanza M Garcia-Oropesa; Juan Carlos Lopez-Alvarenga; John B Prins; Gerhard Walzl; Larry S Schlesinger; Katharina Ronacher Journal: Tuberculosis (Edinb) Date: 2018-08-18 Impact factor: 3.131
Authors: S K Rahamon; U A Fabian; M A Charles-Davies; J A Olaniyi; A A Fasanmade; K S Akinlade; O E Oyewole; M O Owolabi; J R Adebusuyi; O O Hassan; B M Ajobo; M O Ebesunun; K Adigun; O O Popoola; W Omiyale; O G Arinola; E O Agbedana Journal: Afr Health Sci Date: 2017-06 Impact factor: 0.927
Authors: Tandi E Matsha; Shanel Raghubeer; Abegail M Tshivhase; Saarah F G Davids; Gloudina M Hon; Lise Bjørkhaug; Rajiv T Erasmus Journal: Appl Clin Genet Date: 2020-12-14
Authors: Florence E Davidson; Tandi E Matsha; Rajiv T Erasmus; Andre Pascal Kengne; Julia H Goedecke Journal: Cardiovasc J Afr Date: 2019-09-12 Impact factor: 1.167
Authors: Clara Marincowitz; Ingrid Webster; Corli Westcott; Nandu Goswami; Patrick de Boever; Gerald Seidel; Hans Strijdom Journal: Cardiovasc J Afr Date: 2020-11-13 Impact factor: 1.167
Authors: Faheema Kimmie-Dhansay; Carla Cruvinel Pontes; Usuf M E Chikte; Albert Chinhenzva; Rajiv T Erasmus; Andre Pascal Kengne; Tandi E Matsha Journal: Int J Environ Res Public Health Date: 2021-05-08 Impact factor: 3.390